Revolution Medicines (RVMD) officer exercises options, sells 37,450 shares under 10b5-1 plan
Rhea-AI Filing Summary
Revolution Medicines, Inc. officer Anthony Mancini exercised options and sold shares of common stock. He exercised options for 37,450 shares of common stock at an exercise price of $33.6200 per share and received 37,450 shares.
On the same date, he sold a total of 37,450 shares in multiple open-market transactions at prices ranging from $93.2230 to $97.2071, pursuant to a Rule 10b5-1 trading plan adopted on December 24, 2025. After these transactions, he directly holds 54,800 shares of common stock, which the footnotes state includes 54,400 restricted stock units.
Positive
- None.
Negative
- None.
Insights
Exercise-and-sell under a 10b5-1 plan, with sizable shares retained.
Anthony Mancini exercised stock options for 37,450 shares at an exercise price of $33.6200 and sold the same number of shares in open-market trades between $93.2230 and $97.2071. This is a classic exercise-and-sell pattern.
The filing specifies that these trades were made under a Rule 10b5-1 trading plan adopted on December 24, 2025, indicating they were pre-planned rather than opportunistic. Following the transactions, Mancini still directly holds 54,800 shares of common stock, including 54,400 restricted stock units, so he retains a meaningful equity stake.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 37,450 | $0.00 | -- |
| Exercise | Common Stock | 37,450 | $33.62 | $1.26M |
| Sale | Common Stock | 1,800 | $93.223 | $168K |
| Sale | Common Stock | 3,128 | $94.1561 | $295K |
| Sale | Common Stock | 21,086 | $95.4859 | $2.01M |
| Sale | Common Stock | 11,036 | $96.4299 | $1.06M |
| Sale | Common Stock | 400 | $97.2071 | $39K |
Footnotes (1)
- Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025. Includes 54,400 Restricted Stock Units. This transaction was executed in multiple trades at prices ranging from $92.69 to $93.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $93.75 to $94.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $95.00 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $96.00 to $96.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $97.12 to $97.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
